European Markets for Diabetes Monitoring, Treatment and Drug Delivery

NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Markets for Diabetes Monitoring, Treatment and Drug Delivery

http://www.reportlinker.com/p01093084/European-Markets-for-Diabetes-Monitoring-Treatment-and-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

Report Contents:

- Competitor Analysis

- Identified Strategic Opportunities

- Market Overview by Segment & Country

- Trend Analysis by Segment & Country

- Market Drivers & Limiters

- Mergers & Acquisitions

- Customer Feedback and Market Monitoring

Main Segments Included:

- Traditional blood glucose monitoring

- Blood glucose meters

- Blood glucose test strips

- Lancets and lancing devices

- Insulin

- Insulin syringes

- Insulin pens

- Insulin pumps

- Artificial pancreas

Companies Listed in Report:

- Sanofi

- Johnson & Johnson

- Eli Lilly

- Abbott

- Roche

- Bayer

- Medtronic

- Menarini

- Artsana

- Becton Dickinson

- Terumo

- Sooil

- B Braun

- Dexcom

- Novo Nordisk

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods.

EXECUTIVE SUMMARY1

1.1 EUROPEAN MARKETS FOR DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY.1

1.2 TRADITIONAL BLOOD GLUCOSE MONITORING MARKET2

1.3 CONTINUOUS GLUCOSE MONITORING MARKET .3

1.4 INSULIN MARKET4

1.5 INSULIN PEN MARKET ..4

1.6 INSULIN SYRINGE MARKET 5

1.7 INSULIN PUMP MARKET ..6

1.8 LEADING COMPETITORS ..7

RESEARCH METHODOLOGY8

2.1 RESEARCH SCOPE ..8

2.2 IDATA'S 9-STEP METHODOLOGY 8

Step 1: Project Initiation & Team Selection..9

Step 2: Prepare Data Systems and Perform Secondary Research ..11

Step 3: Preparation for Interviews & Questionnaire Design.12

Step 4: Performing Primary Research ..13

Step 5: Research Analysis: Establishing Baseline Estimates.15

Step 6: Market Forecast and Analysis16

Step 7: Identify Strategic Opportunities18

Step 8: Final Review and Market Release19

Step 9: Customer Feedback and Market Monitoring .19

EUROPEAN DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET.20

3.1 INTRODUCTION .20

3.1.1 Types of Diabetes .20

3.1.1.1 Type 1 Diabetes .20

3.1.1.2 Type 2 Diabetes .20

3.1.1.3 Gestational Diabetes ..21

3.1.1.4 Prediabetes.21

3.1.2 Diabetes Complications 22

3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes.24

3.1.4 Signs and Symptoms 25

3.1.5 Diabetes Monitoring..26

3.1.5.1 Initial Diagnosis..26

3.1.5.2 Blood Glucose Monitoring Systems.27

3.1.5.3 Urinary Glucose Monitoring..27

3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices..27

3.1.6 Treatment 29

3.1.6.1 Lifestyle Measures..29

3.1.6.2 Insulin29

3.1.6.3 Insulin Types .29

3.1.6.4 Oral Antidiabetic Drugs29

3.1.6.5 Injectable Antidiabetic Drugs 30

3.1.7 Drug Delivery Systems ..30

3.1.7.1 Insulin Syringes .30

3.1.7.2 Insulin Pens 30

3.1.7.3 Insulin Pumps30

3.1.7.4 Inhaled Insulin..30

3.2 CURRENCY EXCHANGE RATE.32

3.3MARKET OVERVIEW..33

3.4 TREND ANALYSIS BY SEGMENT 39

3.5MARKET DRIVERS AND LIMITERS 42

3.5.1 Market Drivers .42

3.5.2 Market Limiters 43

3.6 COMPETITIVE ANALYSIS ..45

3.6.1 Leading Competitors ..45

3.6.2 Market Concentration 51

3.7MERGERS AND ACQUISITIONS53

COUNTRY PROFILES54

4.1 INTRODUCTION .54

4.1.1 Population ..54

4.1.2 GDP per Capita54

4.1.3 Units ..54

4.1.4 Price Index .54

4.2 GERMANY55

4.3 FRANCE.56

4.4 UNITED KINGDOM ..57

4.5 ITALY.58

4.6 SPAIN .59

4.7 BENELUX .60

4.8 SCANDINAVIA61

4.9 AUSTRIA ..62

4.10 SWITZERLAND 63

4.11 PORTUGAL 64

TRADITIONAL BLOOD GLUCOSE MONITORING MARKET..65

5.1 INTRODUCTION .65

5.2MARKET OVERVIEW..67

5.3MARKET ANALYSIS AND FORECAST ..71

5.4MARKET DRIVERS AND LIMITERS 75

5.4.1 Market Drivers .75

5.4.2 Market Limiters 76

5.5 COMPETITIVE ANALYSIS ..77

BLOOD GLUCOSE METER MARKET ..82

6.1 INTRODUCTION .82

6.2MARKET ANALYSIS AND FORECAST ..83

6.3MARKET DRIVERS AND LIMITERS 90

6.3.1 Market Drivers .90

6.3.2 Market Limiters 90

6.4 COMPETITIVE ANALYSIS ..92

BLOOD GLUCOSE TEST STRIP MARKET97

7.1 INTRODUCTION .97

7.2MARKET ANALYSIS AND FORECAST ..98

7.3MARKET DRIVERS AND LIMITERS .105

7.3.1 Market Drivers ..105

7.3.2 Market Limiters .106

7.4 COMPETITIVE ANALYSIS 107

LANCET AND LANCING DEVICE MARKET 112

8.1 INTRODUCTION ..112

8.2MARKET ANALYSIS AND FORECAST 113

8.3MARKET DRIVERS AND LIMITERS .120

8.3.1 Market Drivers ..120

8.3.2 Market Limiters .120

8.4 COMPETITIVE ANALYSIS 122

CONTINUOUS GLUCOSE MONITORING MARKET..128

9.1 INTRODUCTION ..128

9.2MARKET OVERVIEW129

9.2.1 Total CGM Market 129

9.2.2 Emerging Markets: Non-Invasive CGM.129

9.3MARKET ANALYSIS AND FORECAST 133

9.3.1 Total CGM Market 133

9.3.2 CGM System Market 135

9.3.3 CGM Sensor Market.136

9.4MARKET DRIVERS AND LIMITERS .137

9.4.1 Market Drivers ..137

9.4.2 Market Limiters .138

9.5 COMPETITIVE ANALYSIS 140

INSULIN MARKET .143

10.1 INTRODUCTION 143

10.1.1 Insulin Types 143

10.2MARKET ANALYSIS AND FORECAST .146

10.3MARKET DRIVERS AND LIMITERS ..153

10.3.1 Market Drivers .153

10.3.2 Market Limiters 154

10.4 COMPETITIVE ANALYSIS .155

INSULIN PEN MARKET .157

11.1 INTRODUCTION 157

11.2MARKET ANALYSIS AND FORECAST .158

11.3MARKET DRIVERS AND LIMITERS ..165

11.3.1 Market Drivers .165

11.3.2 Market Limiters 165

11.4 COMPETITIVE ANALYSIS .166

INSULIN SYRINGE MARKET168

12.1 INTRODUCTION 168

12.2MARKET ANALYSIS AND FORECAST .169

12.3MARKET DRIVERS AND LIMITERS ..176

12.3.1 Market Drivers .176

12.3.2 Market Limiters 176

12.4 COMPETITIVE ANALYSIS .178

INSULIN PUMP MARKET.182

13.1 INTRODUCTION 182

13.2MARKET OVERVIEW.184

13.3MARKET ANALYSIS AND FORECAST .188

13.3.1 Total Traditional Insulin Pump Market ..188

13.3.1.1 Traditional Insulin Pump Market193

13.3.1.2 Infusion Set Market 199

13.3.2 Emerging Markets: Patch Pump Market205

13.3.2.1 Patch Pump PDM Market ..207

13.3.2.2 Insulin Pod Market.208

13.3.3 Emerging Markets: Simple Pump Market ..209

13.4MARKET DRIVERS AND LIMITERS ..211

13.4.1 Market Drivers .211

13.4.2 Market Limiters 212

13.5 COMPETITIVE ANALYSIS .214

13.5.1 Traditional Pump Market Competitors 214

13.5.2 Patch Pump Market Competitors 218

13.5.3 Emerging Competitors .219

APPENDIX 1: ARTIFICIAL PANCREAS 220

14.1MECHANICAL ARTIFICIAL PANCREAS..220

14.2 BIO-ARTIFICIAL PANCREAS221

ABBREVIATIONS ..222

To order this report:

In_Vitro_Diagnostic Industry: European Markets for Diabetes Monitoring, Treatment and Drug Delivery

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker